Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

AGM Statement

28 Jul 2009 07:00

RNS Number : 3620W
Imaginatik PLC
28 July 2009
Β 

ο»Ώ

28 JulyΒ 2009

ImaginatikΒ plc

("Imaginatik" or the "Company")

AGM Statement

Howard Marshall, ChairmanΒ of Imaginatik plc (AIM: IMTK), a leading provider ofΒ enterpriseΒ collaborative software and processes,Β will make the following statement at the Company'sΒ Annual General Meeting to be held laterΒ today:

"As with last year, the new financial year has started slowlyΒ withΒ prospective clientsΒ continuing to beΒ cautious in their commitment to spend.Β However, we are pleased to announceΒ several good client wins of late through our strategic partnership withΒ HultΒ BusinessΒ School, resulting inΒ ourΒ IdeaΒ Central software being used at Osram Sylvania, Philips Medical Systems, Siemens andΒ BAEΒ Systems amongst others.

Consistent with previous years, we anticipate that the larger part of our revenues will come in the second half of the financial year and, as expected, the Company will incur a loss in the six months toΒ 30 September 2009. Despite the difficult market conditions and economic uncertainties, we still anticipate another year of revenue growth for the Company and continue to remain optimistic in our sales pipeline which is developing well as a result of our increased focus on marketing the Company and our software and services offering."

Β 

For further information please contact:

Imaginatik plc

Tel: 020 7917 2975

Mark Turrell, CEO / Shawn Taylor, CFO

Arbuthnot Securities Limited

Tel: 020 7012 2000

Tom Griffiths

ICIS

Tel: 020 7651 8688

Tom Moriarty / Caroline Evans-Jones

About Imaginatik

Imaginatik isΒ aΒ leading provider of web-basedΒ enterpriseΒ collaboration software. Imaginatik's core software, Idea Central, is designed to help companies focus on idea generation towards strategic business objectives, and to share, develop and review those ideas across the organisation. Some of the world's largestΒ organisations such as Merck, Dow, Chevron, General Electric and CargillΒ use Imaginatik's software, consulting and leading-edge research to enable their best-of-breed innovation, cost-reduction and process improvement activities.

Having been named as a World Economic Forum Technology Pioneer and a finalist for the IBM Lotus Awards in the Best Industry Solution category, Imaginatik's software and consulting services have helped clients discover significant sources of additional revenue, as well as tangible cost savings. Imaginatik is also committed to developing strategic solutions in the field of innovation, working with academic institutions such as theΒ HultΒ BusinessΒ SchoolΒ inΒ Boston, and the Cass School of Business,Β London, as well as leading practitioners of corporate innovation.

For further information please visit http://www.imaginatik.com

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
AGMGGGZNNNKGLZM
Date   Source Headline
28th Jul 20154:07 pmRNSHolding(s) in Company
24th Jul 201512:50 pmRNSHolding(s) in Company
21st Jul 20155:31 pmRNSHolding(s) in Company
20th Jul 20157:00 amRNSSubscription and Director Dealings
15th Jul 20157:00 amRNSFinal Results
10th Jul 20159:23 amRNSHolding(s) in Company
1st Jul 20157:00 amRNSContract Win
29th Jun 20155:11 pmRNSHolding(s) in Company
29th Jun 20155:10 pmRNSHolding(s) in Company
29th Jun 201510:30 amRNSHolding(s) in Company
25th Jun 20157:00 amRNSHolding(s) in Company
25th Jun 20157:00 amRNSHolding(s) in Company
23rd Jun 20155:15 pmRNSHolding(s) in Company
23rd Jun 20157:00 amRNSHolding(s) in Company
22nd Jun 20157:00 amRNSMarket Update
1st Jun 20152:38 pmRNSResult of General Meeting
15th May 20157:00 amRNSPosting of Circular
14th May 20157:00 amRNSProposed Issue of Equity
13th Apr 20157:00 amRNSContract Wins
30th Mar 20157:00 amRNSContract Extension
16th Feb 20157:00 amRNSContracts win
11th Feb 20158:05 amRNSTrading Update
19th Jan 20157:00 amRNSDirector Loan
22nd Dec 201410:30 amRNSGrant of Options
17th Dec 20147:00 amRNSFive Year Contract Win
16th Dec 20147:00 amRNSContract Win
8th Dec 20147:00 amRNSInterim Results
19th Nov 20147:00 amRNSDirectorate Change
14th Nov 201411:52 amRNSBlocklisting Interim Review
24th Oct 20147:00 amRNSIssue of Equity/Director's Dealing
7th Oct 20145:04 pmRNSDirector/PDMR Shareholding
27th Aug 201410:50 amRNSHolding(s) in Company
21st Aug 20141:31 pmRNSDirector/PDMR Shareholding
18th Aug 20141:37 pmRNSHolding(s) in Company
14th Aug 20141:38 pmRNSResult of AGM
22nd Jul 20147:00 amRNSProposed Share Consolidation and Notice of AGM
1st Jul 20147:00 amRNSFinal Results
16th May 201411:40 amRNSHolding(s) in Company
15th May 20148:50 amRNSBlocklisting Interim Review
13th May 201411:47 amRNSHolding(s) in Company
12th May 20144:14 pmRNSResult of General Meeting and Exercise of Options
25th Apr 20147:00 amRNSProposed Placing and Subscription
14th Apr 20147:00 amRNSContract Wins and Trading Update
18th Mar 20147:00 amRNSContract Wins
28th Feb 201410:35 amRNSDirector's Dealing
26th Feb 201412:39 pmRNSDirector's Dealing
19th Dec 20133:38 pmRNSHolding(s) in Company
18th Dec 20137:00 amRNSExercise and Grant of Options
13th Dec 20137:00 amRNSContract Extension
3rd Dec 20137:00 amRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.